focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks jump to four-week high as Syria concerns ease

Tue, 10th Sep 2013 16:40

The FTSE 100 jumped to a four-week high on Tuesday as investors' fears of an impending US military strike on Syria eased and the economic outlook for China improved.London's benchmark index finished 53.25 points higher at 6,583.99, a gain of 0.82%; the last time it closed higher was on August 14th when it ended the day at 6,587.43."The FTSE 100 is knocking on the door of 6,600 for the first time since mid-August, as investors look to make gains before the crucial Fed meeting next week," said Market Analyst Chris Beauchamp from IG. Friday's disappointing US non-farm payrolls figure has increased hopes that the Federal Reserve could delay a move to taper its stimulus programme until later this year.Markets started on the front foot this morning on the back of a continuing improvement in economic data from China with the third-quarter outlook for the Asian powerhouse continuing to brighten. Industrial output, fixed-asset investment and retail sales strengthened during the month of August, with all three economic indicators rising by more than expected. This followed yesterday's news that exports rose more than expected in August, while consumer price inflation eased.Stocks then extended gains in the afternoon as Wall Street indices reacted positively to developments in Syria, with the S&P 500 extending its recent winning streak into the sixth day, its longest string of positive sessions since mid-July.Positive developments in SyriaSyria said today that it has accepted a Russian-backed proposal to give up chemical weapons to international control in an attempt to avoid US military action, according to Russian news agency Interfax. This follows the request by Russian Foreign Minister Sergei Lavrov yesterday to give up any chemical weapons they may.Syria's Foreign Minister Walid Muallem said that he agreed to the proposals to "remove the grounds for American aggression".IG's Beauchamp said: "If you'd been asked to suggest a possible starting point for a solution to the Syrian crisis, I suspect Russia would not have been at the top of the list. "Nevertheless, it now seems as if Moscow could find a way to take some of the heat out of the situation. As a result, markets have breathed a sigh of relief, with stock indices gaining and gold and oil giving back much of their recent gains."All eyes now turn to US President Barack Obama ahead of a speech in Washington tonight where he is expected to outline his intentions for the next course of action regarding Syria.FTSE 100: Airlines flying high, miners track metals lowerAirline groups IAG and easyJet were flying higher with crude continuing to pull back from its recent highs as fears over turmoil in the Middle East ease. Elevated oil prices have pressured both stocks over the last few weeks on concerns over the knock-on effects to jet fuel costs. Shares in easyJet were also helped by comments from Chief Executive Carolyn McCall who said in an interview that the company will be "Europe's preferred airline in five years' time" due to its low-cost operating model.easyJet rose yesterday after Bank of America Merrill Lynch predicted that October's fourth-quarter trading update would see a continuation of its robust yield performance, and suggested a special dividend could also be on the cards. Monday also saw the company add two new routes, with seats to go on sale from next month.Financials were also performing well today with RBS, Standard Chartered, Aberdeen Asset Management, Prudential, Hargreaves Lansdown and Aviva among the highest risers.Leading the downside were the miners as metal prices fell across the board. Precious metals peers Randgold and Fresnillo were among the worst performers as gold futures dropped to a two-week low. Recently-merged Glencore Xstrata however bucked the trend after lifting its synergy target to at least $2bn next year as the miner vowed to cut costs and improve operational efficiency. Pharma giant GlaxoSmithKline fell sharply after US regulators set out requirements for generic versions of its lung drug Advair, sparking competition concerns over when patents run out in a few years' time.Costa and Premier Inn owner Whitbread was also down after seeing sales growth slow from 13.8% in the first quarter to just 10.8% in the second as the hot summer weather hit demand at its coffee shops.Broker comments were also moving a number of blue-chip stocks: Drinks giant SABMiller was on the climb this morning after HSBC upgraded the stock to 'overweight'; consumer products group Unilever was lifted by Deutsche Bank to 'buy'; and Babcock was higher after JPMorgan labelled the engineering support services company as its top pick in the sector.FTSE 250: Ashmore jumps, Oxford Instruments slumpsRecord subscriptions helped emerging markets asset manager Ashmore to drive strong net inflows into its funds in the year to June, giving the share price a boost this morning. Strong net inflows of $13.4bn led to a 22% increase in assets under management (AuM) to $77.4bn during the year, with average AuM rising 13%.Oxford Instruments was a heavy faller after saying that while growth in the order intake rate in Industrial Products and third party Service is encouraging, slowness in R&D markets in the Western economies means that the year is likely to be more second half-weighted.Shares in chip designer Imagination Technologies jumped today ahead of an Apple event in California where the tech giant - a key customer for Imagination - is expected to unveil its latest iPhone.FTSE 100 - RiserseasyJet (EZJ) 1,358.00p +7.18%Royal Bank of Scotland Group (RBS) 356.00p +4.71%International Consolidated Airlines Group SA (CDI) (IAG) 319.80p +4.68%Carnival (CCL) 2,450.00p +4.26%Aberdeen Asset Management (ADN) 384.10p +4.04%Standard Chartered (STAN) 1,511.00p +3.81%Legal & General Group (LGEN) 199.60p +2.99%Prudential (PRU) 1,171.00p +2.99%SABMiller (SAB) 3,174.00p +2.88%Weir Group (WEIR) 2,344.00p +2.85%FTSE 100 - FallersRandgold Resources Ltd. (RRS) 4,689.00p -4.58%Fresnillo (FRES) 1,225.00p -3.47%GlaxoSmithKline (GSK) 1,598.50p -2.53%Whitbread (WTB) 3,138.00p -2.43%Eurasian Natural Resources Corp. (ENRC) 221.00p -1.69%Vodafone Group (VOD) 207.90p -1.19%BG Group (BG.) 1,205.00p -0.99%Rolls-Royce Holdings (RR.) 1,131.00p -0.26%Tullow Oil (TLW) 1,057.00p -0.19%Vedanta Resources (VED) 1,188.00p -0.17%FTSE 250 - RisersAshmore Group (ASHM) 382.20p +5.32%Imagination Technologies Group (IMG) 302.00p +5.19%Fenner (FENR) 389.50p +5.01%Laird (LRD) 234.70p +4.96%Ferrexpo (FXPO) 187.00p +4.64%Galliford Try (GFRD) 1,070.00p +4.59%Henderson Group (HGG) 187.10p +4.53%Synthomer (SYNT) 249.20p +4.40%Ocado Group (OCDO) 365.00p +4.29%Greggs (GRG) 438.70p +4.15%FTSE 250 - FallersAfrican Barrick Gold (ABG) 166.40p -9.37%Oxford Instruments (OXIG) 1,404.00p -7.02%Moneysupermarket.com Group (MONY) 168.50p -2.21%Pace (PIC) 280.50p -2.13%Centamin (DI) (CEY) 46.00p -1.96%International Personal Finance (IPF) 640.00p -1.54%Polymetal International (POLY) 756.00p -1.50%Essar Energy (ESSR) 136.70p -1.37%RPS Group (RPS) 257.00p -1.19%ITE Group (ITE) 288.50p -1.13%BC
More News
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.